Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 38
Filtrer
1.
Drug Des Devel Ther ; 18: 2381-2392, 2024.
Article de Anglais | MEDLINE | ID: mdl-38911034

RÉSUMÉ

Purpose: We aimed to evaluate the effect of intravenous esketamine combined with dexmedetomidine as supplemental analgesia in reducing intraoperative visceral pain during elective cesarean section under combined spinal-epidural anesthesia (CSEA). Patients and Methods: A total of 269 parturients scheduled for elective cesarean section under CSEA between May 2023 and August 2023 were assessed. The parturients were randomly allocated to receiving either intravenous infusion of 0.3-mg/kg esketamine combined with 0.5-µg/kg dexmedetomidine (group ED, n=76), 0.5-µg/kg dexmedetomidine (group D, n=76), or normal saline (group C, n=76) after umbilical cord clamping. The primary outcome was intraoperative visceral pain. Secondary outcomes included the visual analog scale (VAS) score for pain evaluation and other intraoperative complications. Results: The incidence of visceral pain was lower in group ED [9 (12.7%)] than in group D [32 (43.8%)] and group C [36 (48.6%), P <0.0001]. The VAS score was also lower in group ED when exploring abdominal cavity [0 (0), P <0.0001] and suturing the muscle layer [0 (0), P =0.036]. The mean arterial pressure was higher in group D [83 (9) mmHg] and group ED [81 (11) mmHg] than in group C [75 (10) mmHg, P <0.0001] after solution infusion. The heart rate after infusion of the solution was lower in group D [80 (12) bpm] than in group C [86 (14) bpm] and group ED [85 (12) bpm, P = 0.016]. The incidence of transient neurologic or mental symptoms was higher in group ED compared to group C and group D (76.1% vs 18.9% vs 23.3%, P<0.0001). Conclusion: During cesarean section, 0.3-mg/kg esketamine combined with 0.5-µg/kg dexmedetomidine can alleviate visceral traction pain and provide stable hemodynamics. Parturients receiving this regimen may experience transient neurologic or mental symptoms that can spontaneously resolve at the end of the surgery.


Some parturients endure experience indescribable pain and discomfort during fetal delivery. Esketamine combined with dexmedetomidine can alleviate this pain during cesarean section under combined spinal-epidural anesthesia. However, after intravenous injection of esketamine and dexmedetomidine, the parturients may experience nightmares, dizziness, hallucinations, and drowsiness, etc.


Sujet(s)
Anesthésie péridurale , Rachianesthésie , Césarienne , Dexmédétomidine , Kétamine , Douleur viscérale , Humains , Dexmédétomidine/administration et posologie , Kétamine/administration et posologie , Méthode en double aveugle , Femelle , Adulte , Douleur viscérale/prévention et contrôle , Douleur viscérale/traitement médicamenteux , Grossesse , Association de médicaments , Interventions chirurgicales non urgentes
2.
Comput Med Imaging Graph ; 115: 102384, 2024 Jul.
Article de Anglais | MEDLINE | ID: mdl-38759471

RÉSUMÉ

BACKGROUND: The KRAS, NRAS, and BRAF genotypes are critical for selecting targeted therapies for patients with metastatic colorectal cancer (mCRC). Here, we aimed to develop a deep learning model that utilizes pathologic whole-slide images (WSIs) to accurately predict the status of KRAS, NRAS, and BRAFV600E. METHODS: 129 patients with left-sided colon cancer and rectal cancer from the Third Affiliated Hospital of Sun Yat-sen University were assigned to the training and testing cohorts. Utilizing three convolutional neural networks (ResNet18, ResNet50, and Inception v3), we extracted 206 pathological features from H&E-stained WSIs, serving as the foundation for constructing specific pathological models. A clinical feature model was then developed, with carcinoembryonic antigen (CEA) identified through comprehensive multiple regression analysis as the key biomarker. Subsequently, these two models were combined to create a clinical-pathological integrated model, resulting in a total of three genetic prediction models. RESULT: 103 patients were evaluated in the training cohort (1782,302 image tiles), while the remaining 26 patients were enrolled in the testing cohort (489,481 image tiles). Compared with the clinical model and the pathology model, the combined model which incorporated CEA levels and pathological signatures, showed increased predictive ability, with an area under the curve (AUC) of 0.96 in the training and an AUC of 0.83 in the testing cohort, accompanied by a high positive predictive value (PPV 0.92). CONCLUSION: The combined model demonstrated a considerable ability to accurately predict the status of KRAS, NRAS, and BRAFV600E in patients with left-sided colorectal cancer, with potential application to assist doctors in developing targeted treatment strategies for mCRC patients, and effectively identifying mutations and eliminating the need for confirmatory genetic testing.


Sujet(s)
Tumeurs colorectales , dGTPases , Génotype , Protéines membranaires , , Protéines proto-oncogènes B-raf , Protéines proto-oncogènes p21(ras) , Humains , Protéines proto-oncogènes B-raf/génétique , Tumeurs colorectales/génétique , Tumeurs colorectales/anatomopathologie , Protéines proto-oncogènes p21(ras)/génétique , dGTPases/génétique , Protéines membranaires/génétique , Femelle , Mâle , Adulte d'âge moyen , Sujet âgé , Apprentissage profond , Adulte , Mutation
3.
J Gastrointest Surg ; 28(5): 656-661, 2024 May.
Article de Anglais | MEDLINE | ID: mdl-38704202

RÉSUMÉ

BACKGROUND: Asymptomatic gallstones are commonly detected using preoperative imaging in patients with colorectal cancer (CRC), but its management remains a topic of debate. METHODS: Clinicopathologic characteristics of patients who had asymptomatic gallstones presenting during the colorectal procedure were retrospectively reviewed. Medical records, including postoperative morbidity, mortality, and long-term gallstone-related diseases, were assessed. RESULTS: Of 134 patients with CRC having asymptomatic gallstones, 89 underwent elective colorectal surgery only (observation group), and 45 underwent elective colorectal surgery with simultaneous cholecystectomy (cholecystectomy group). After propensity score matching (PSM), the complications were similar in the 2 groups. During the follow-up period, biliary complications were noted in 11 patients (12.4%) in the observation group within 2 years after the initial CRC surgery, but no case was found in the cholecystectomy group. After PSM, the incidence of long-term biliary complications remained significantly higher in the observation group than in the cholecystectomy group (26.5% vs 0.0%; P < .01). Multivariable logistic regression analysis identified female gender, old age (≥65 years old), and small multiple gallstones as independent risk factors for the development of long-term gallstone-related diseases in patients from the observation group. CONCLUSION: Simultaneous prophylactic cholecystectomy during prepared, elective CRC surgery did not increase postoperative morbidity or mortality but decreased the risk of subsequent gallstone-related complications. Hence, simultaneous cholecystectomy might be a preferred therapeutic option for patients with CRC having asymptomatic gallstones in cases of elective surgery, especially for older patients (≥65 years old), female patients, and those with small multiple calculi.


Sujet(s)
Maladies asymptomatiques , Cholécystectomie , Tumeurs colorectales , Interventions chirurgicales non urgentes , Calculs biliaires , Humains , Femelle , Mâle , Calculs biliaires/chirurgie , Calculs biliaires/complications , Sujet âgé , Interventions chirurgicales non urgentes/effets indésirables , Tumeurs colorectales/chirurgie , Études rétrospectives , Adulte d'âge moyen , Cholécystectomie/effets indésirables , Score de propension , Facteurs de risque , Facteurs âges , Sujet âgé de 80 ans ou plus , Complications postopératoires/épidémiologie , Complications postopératoires/étiologie , Facteurs sexuels
4.
Immun Inflamm Dis ; 12(2): e1187, 2024 Feb.
Article de Anglais | MEDLINE | ID: mdl-38353388

RÉSUMÉ

BACKGROUND: Sepsis is a severe complication that results in increased morbidity and mortality after intestinal obstruction surgery. This study examined the role of preoperative systemic immune inflammation index (SII) for postoperative sepsis in intestinal obstruction patients. METHODS: Data on patients who underwent intestinal obstruction surgery were collected. SII was determined and separated into two groups (≤1792.19 and >1792.19) according to the optimal cut-off value of SII for postoperative sepsis. The odds ratio (OR) is calculated for the correlation between SII and postoperative sepsis. Additional analyses were used to estimate the robustness of SII. RESULTS: A total of 371 intestinal obstruction patients undergoing surgery were included in the final cohort, and 60 (16.17%) patients developed postoperative sepsis. Patients with an SII >1792.19 had a significantly higher risk for developing postoperative sepsis after multivariable adjustment [adjusted odds ratio = 2.12, 95% confidence interval: [1.02-4.40]]. The analysis of interaction showed no correlation between the preoperative SII and postoperative sepsis regarding age, hypertension, American Society of Anesthesiologists classification, blood loss, albumin, hemoglobin, creatinine, and leukocyte (all interactions p > .05). In subgroup analysis, all statistically significant subgroups showed that SII was a risk factor for postoperative sepsis (all p < .05). The analyses of subgroups and interactions revealed that the interaction effect of a preoperative SII >1792.19 and postoperative sepsis remained significant. A sensitivity analysis confirmed the robustness of the results. CONCLUSIONS: A preoperative SII > 1792.19 was a risk factor for postoperative sepsis in patients undergoing intestinal obstruction surgery.


Sujet(s)
Occlusion intestinale , Sepsie , Humains , Études rétrospectives , Inflammation , Facteurs de risque , Occlusion intestinale/étiologie , Occlusion intestinale/chirurgie , Sepsie/complications
6.
Front Oncol ; 13: 906514, 2023.
Article de Anglais | MEDLINE | ID: mdl-37064099

RÉSUMÉ

Background: Dexmedetomidine (DEX) has been widely applied in the anesthesia and sedation of patients with oncological diseases. However, the potential effect of DEX on tumor metastasis remains contradictory. This study follows up on patients who received intraoperative DEX during laparoscopic resection of colorectal cancer as part of a previous clinical trial, examining their outcomes 5 years later. Methods: Between June 2015 and December 2015, 60 patients undergoing laparoscopic colorectal resection were randomly assigned to the DEX and control groups. The DEX group received an initial loading dose of 1µ/kg before surgery, followed by a continuous infusion of 0.3µg/kg/h during the operation and the Control group received an equivalent volume of saline. A 5-year follow-up analysis was conducted to evaluate the overall survival, disease-free survival, and tumor recurrence. Results: The follow-up analysis included 55 of the 60 patients. The DEX group included 28 patients, while the control group included 27 patients. Baseline characteristics were comparable between the two groups, except for vascular and/or neural invasion of the tumor in the DEX group (9/28 vs. 0/27, p = 0.002). We did not observe a statistically significant benefit but rather a trend toward an increase in overall survival and disease-free survival in the DEX group, 1-year overall survival (96.4% vs. 88.9%, p = 0.282), 2-year overall survival (89.3% vs. 74.1%, p = 0.144), 3-year overall survival (89.3% vs. 70.4%, p = 0.08), and 5-year overall survival (78.6% vs. 59.3%, p = 0.121). The total rates of mortality and recurrence between the two groups were comparable (8/28 vs. 11/27, p = 0.343). Conclusion: Administration of DEX during laparoscopic resection of colorectal cancer had a nonsignificant trend toward improved overall survival and disease-free survival. Clinical Trial Registration: http://www.chictr.org.cn/, identifier ChiCTRIOR-15006518.

7.
Tissue Cell ; 80: 102001, 2023 Feb.
Article de Anglais | MEDLINE | ID: mdl-36565506

RÉSUMÉ

Intestinal ischemia-reperfusion (II/R) injury is a common clinical and pathological change; however, its underlying mechanisms remain unclear. Previous studies have shown that the inflammatory response induced by mast cell degranulation may be involved in the mechanism underlying II/R injury in rats. In this study, we established a human intestinal epithelial adenocarcinoma cell (Caco-2) hypoxia/reoxygenation (H/R) model and transwell system to investigate the effects of culture media (CM) from hypoxia conditioned human mast cell (HMC-1) and HMC-1 H/R on hypoxia/reoxygenation injury in Caco-2 under H/R conditions. Moreover, we assessed the barrier function of Caco-2 by measuring the 4-kDa fluorescein isothiocyanate (FITC)-dextran (FD4) flux and the tight junction protein expression. The results concluded that Caco-2 exposed to H/R insult showed an increase in lactate dehydrogenase (LDH) release, cell apoptosis index, cell permeability, Bax expression, phosphorylation of c-Jun N-terminal protein kinase (JNK) and p38, and a decrease in cell viability and expression of Bcl-2, ZO1, and occludin (all P < 0.05). Notably, preincubating Caco-2 with HMC-1CM resulted in an increase in cell injury (increased LDH levels and cell permeability, decreased cell viability), apoptosis index, p-JNK, and p-38 expression and a decrease in ZO1 and occludin expression by co-culture system (all P < 0.05). In conclusion, our results show that HMC-1 hypoxic and reoxygenated CM aggravates hypoxic and reoxygenated injury in Caco-2 by increasing the phosphorylation of JNK and p38 in vitro.


Sujet(s)
Mastocytes , Lésion d'ischémie-reperfusion , Animaux , Humains , Rats , Apoptose/physiologie , Cellules Caco-2 , Milieux de culture , Hypoxie/métabolisme , Mastocytes/métabolisme , Occludine/métabolisme , Lésion d'ischémie-reperfusion/anatomopathologie , Oxygène/métabolisme
8.
Appl Opt ; 60(13): 3784-3790, 2021 May 01.
Article de Anglais | MEDLINE | ID: mdl-33983312

RÉSUMÉ

The SPICA far-infrared instrument (SAFARI), one of instruments of the space infrared telescope for cosmology and astrophysics, requires a calibration source assembly to calibrate the transition edge sensor readout circuits. A high-performance integrating sphere working at SAFARI wavelength (34-230 µm) is essential. A novel process for preparing terahertz integrating spheres was developed. The aluminum surfaces after sandblasting, wet-etching, and gold plating processes demonstrate rough morphology but high reflectance of 0.91 in 1-10 THz. The spatial distribution of the measured output power excellently agrees with the numerical simulation results based on the assumption of uniform surface radiation at the output port.

9.
Biosci Rep ; 40(1)2020 01 31.
Article de Anglais | MEDLINE | ID: mdl-31789347

RÉSUMÉ

BACKGROUND: Hydrogen-rich saline (HRS) has been proven effective against ischemia/reperfusion (I/R) injury. However, knowledge on the underlying signaling events remain poor. Having recent highlight of microRNAs (miRNAs) in mediating intestinal I/R injury, we hypothesized that HRS may protect intestine against I/R injury by regulating miRNAs. METHOD: Mice were given intraperitoneal injection of saline or HRS once daily for five consecutive days before undergoing intestinal I/R that was induced by 60-min ischemia followed by 180-min reperfusion of superior mesenteric artery. The intestine was collected for histopathological assay, miRNA microarray profiling, Real-Time PCR, and Western blotting. Next, miR-199a-3p mimics or inhibitors were transfected into IEC-6 cells to explore the relationship between HRS treatment and miR-199a-3p. RESULTS: I/R-induced mucosal injury and epithelial cells apoptosis were attenuated by HRS pretreatment. A total of 64 intestinal I/R-responsive miRNAs were altered significantly by HRS pretreatment, in which we validated four novel miRNAs with top significance by Real-Time PCR, namely miR-199a-3p, miR-296-5p, miR-5126, and miR-6538. Particularly, miR-199a-3p was drastically increased by I/R but reduced by HRS. Computational analysis predicts insulin-like growth factor (IGF)-1, mammalian target of rapamycin (mTOR), and phosphoinositide-3-kinase (PI3K) regulatory subunit 1 as targets of miR-199a-3p, suggesting involvement of the pro-survival pathway, IGF- 1/PI3K/Akt/mTOR. In in vitro experiment, HRS treatment reduced miR-199a-3p level, increase IGF-1, PI3K and mTOR mRNA expression, restore IEC-6 cells viability, and this protective effects were reversed under miR-199a-3p mimics treatment. CONCLUSION: Collectively, miR-199a-3p may serve a key role in the anti-apoptotic mechanism of HRS that contributes to its protection of the intestine against I/R injury.


Sujet(s)
Apoptose/effets des médicaments et des substances chimiques , Maladies intestinales/prévention et contrôle , Muqueuse intestinale/effets des médicaments et des substances chimiques , Intestin grêle/effets des médicaments et des substances chimiques , microARN/métabolisme , Lésion d'ischémie-reperfusion/prévention et contrôle , Solution physiologique salée/administration et posologie , Animaux , Lignée cellulaire , Modèles animaux de maladie humaine , Régulation de l'expression des gènes , Injections péritoneales , Maladies intestinales/génétique , Maladies intestinales/métabolisme , Maladies intestinales/anatomopathologie , Muqueuse intestinale/métabolisme , Muqueuse intestinale/anatomopathologie , Intestin grêle/métabolisme , Intestin grêle/anatomopathologie , Mâle , Souris de lignée C57BL , microARN/génétique , Lésion d'ischémie-reperfusion/génétique , Lésion d'ischémie-reperfusion/métabolisme , Lésion d'ischémie-reperfusion/anatomopathologie , Transduction du signal , Transcriptome
10.
Eur J Anaesthesiol ; 37(1): 5-13, 2020 Jan.
Article de Anglais | MEDLINE | ID: mdl-31688331

RÉSUMÉ

BACKGROUND: Postictal delirium (PID) is a relatively common complication following electroconvulsive therapy (ECT). OBJECTIVE: We investigated whether prophylactic dexmedetomidine administration would safely decrease the incidence of PID in psychiatric patients after ECT. DESIGN: A randomised, double-blind, placebo-controlled trial. PATIENTS: A total of 223 patients undergoing ECT were randomly allocated to two groups. INTERVENTIONS: Patients received 0.5 µg kg dexmedetomidine (Dex group, n=111) or 0.9% sodium chloride (Con group, n=112) before ECT. Propofol was used for anaesthesia and succinylcholine for muscle relaxation. The incidence of PID was measured using the Confusion Assessment Method for the Intensive Care Unit. MAIN OUTCOME MEASURES: The percentage of patients who were diagnosed with PID at any ECT session during the whole treatment. RESULTS: PID occurred in 76 (67.9%) of 112 patients given saline (0.9% sodium chloride), and in 49 (44.1%) of 111 patients given dexmedetomidine during the whole treatment. There was a significant difference in the incidence of PID between two groups (P < 0.001). Post hoc analyses showed that the incidence of PID was significantly lower in the Dex group than in the Con group from the first to the seventh ECT session (P < 0.005). There were no significant differences in seizure duration or recovery time between the two groups. Heart rate and mean arterial pressure in the Dex group were significantly lower than in the Con group at 0, 5 and 15 min after electrical stimulation. No patients developed bradycardia, hypotension or respiratory depression during recovery. CONCLUSION: Pretreatment with dexmedetomidine leads to a significant reduction in the incidence of PID with no respiratory depressant effect. Dexmedetomidine might be considered an effective method for the prevention of PID post-ECT. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR-IOR-17012306.


Sujet(s)
Délire avec confusion/prévention et contrôle , Dexmédétomidine/administration et posologie , Électroconvulsivothérapie/effets indésirables , Hypnotiques et sédatifs/administration et posologie , Troubles mentaux/thérapie , Crises épileptiques/prévention et contrôle , Adolescent , Adulte , Délire avec confusion/épidémiologie , Délire avec confusion/étiologie , Méthode en double aveugle , Femelle , Humains , Incidence , Mâle , Études prospectives , Crises épileptiques/épidémiologie , Crises épileptiques/étiologie , Résultat thérapeutique , Jeune adulte
11.
Int J Med Sci ; 16(9): 1238-1244, 2019.
Article de Anglais | MEDLINE | ID: mdl-31588189

RÉSUMÉ

Purpose: Acute lung injury (ALI) is a primary component of multiple organ dysfunction syndromes triggered by intestinal ischemia-reperfusion (IIR) which results in high mortality. Existing treatment options remain unsatisfactory. Mesenchymal stem cells (MSCs) have shown considerable promise as a biological therapy for ALI in preclinical studies. However, there are many limitations to stem cell treatment. This study aimed to investigate whether MSC-derived exosomes, a non-cellular alternative, are able to act in a protective capacity similar to that of MSCs for ALI triggered by IIR in a rat model and to explore the underlying mechanisms. Methods: The IIR model involved occlusion of the superior mesenteric artery of a rat for 75 min then reperfusion for 20 h. Rats then received an intravenous injection of either bone marrow-derived MSCs or MSC-derived exosomes. Pathologic alteration of lung tissue, levels of pro-inflammatory cytokines, apoptotic proteins and TLR4/NF-κB signaling were measured to evaluate the therapeutic effect of treatment with either MSCs or exosomes. Results: Manifestations of acute lung injury after IIR were observed as edema and hemorrhage of alveoli and mesenchyme, and inflammatory cell infiltration. MSCs and MSC-derived exosomes both attenuated IIR-induced lung damage by decreased apoptosis and inflammation accompanied by down-regulation of TLR4 and NF-κB expression. Conclusions: MSC-derived exosomes provide protection similar to that of MSCs against IIR-induced ALI via inhibition of TLR4/NF-κB signaling, suggesting that a potential strategy against IIR-mediated acute lung injury could be therapy with exosomes as a non-cellular alternative to MSC transplantation.


Sujet(s)
Lésion pulmonaire aigüe/thérapie , Exosomes , Cellules souches mésenchymateuses/cytologie , Facteur de transcription NF-kappa B/métabolisme , Lésion d'ischémie-reperfusion/complications , Récepteur de type Toll-4/métabolisme , Lésion pulmonaire aigüe/étiologie , Lésion pulmonaire aigüe/anatomopathologie , Animaux , Cytokines/métabolisme , Exosomes/métabolisme , Intestins/vascularisation , Mâle , Rat Sprague-Dawley , Transduction du signal
12.
Mol Med Rep ; 19(5): 3633-3641, 2019 May.
Article de Anglais | MEDLINE | ID: mdl-30864725

RÉSUMÉ

Ginsenoside Rb1 (GRb1), one of the major active saponins isolated from ginseng, has recently been reported to protect various organs against ischemia/reperfusion (IR) injury; however, the mechanisms underlying these protective effects following intestinal IR (IIR) remain unclear. The present study aimed to evaluate the effects of GRb1 on IIR injury and determine the mechanisms involved in these effects. Sprague Dawley rats were subjected to 75 min of superior mesenteric artery occlusion, followed by 3 h of reperfusion. GRb1 (15 mg/kg) was administered intraperitoneally 1 h prior to the induction of IIR, with or without intravenous administration of Wortmannin [WM; a phosphoinositide 3­kinase (PI3K) inhibitor, 0.6 mg/kg]. The degree of intestinal injury and oxidative stress­induced damage was determined by histopathologic evaluation and measurement of the serum activity levels of D­lactate, diamine oxidase and endotoxin, and the levels of malondialdehyde (MDA), superoxide dismutase (SOD) and 8­iso­prostaglandin F2α (8­iso­PGF2α). The protein expression levels of p85, phosphorylated (p)­p85, protein kinase B (Akt), p­Akt and nuclear factor erythroid 2­related factor 2 (Nrf2) were determined via western blotting, and the concentrations of tumor necrosis factor­α (TNF­α), interleukin (IL)­1ß and IL­6 were measured via ELISA. It was revealed that IIR led to severe intestinal injury (as determined by significant increases in intestinal Chiu scores), which was accompanied with disruptions in the integrity of the intestinal mucosal barrier. IIR also increased the expression levels of TNF­α, IL­1ß, IL­6, MDA and 8­iso­PGF2α in the intestine, and decreased those of SOD. GRb1 reduced intestinal histological injury, and suppressed inflammatory responses and oxidative stress. Additionally, the protective effects of GRb1 were eliminated by WM. These findings indicated that GRb1 may ameliorate IIR injury by activating the PI3K/protein kinase B/Nrf2 pathway.


Sujet(s)
Ginsénosides/pharmacologie , Inflammation/étiologie , Facteur-2 apparenté à NF-E2/métabolisme , Stress oxydatif/effets des médicaments et des substances chimiques , Phosphatidylinositol 3-kinase/métabolisme , Protéines proto-oncogènes c-akt/métabolisme , Lésion d'ischémie-reperfusion/complications , Transduction du signal/effets des médicaments et des substances chimiques , Animaux , Marqueurs biologiques , Cytokines/métabolisme , Médiateurs de l'inflammation/métabolisme , Muqueuse intestinale/vascularisation , Muqueuse intestinale/métabolisme , Muqueuse intestinale/anatomopathologie , Mâle , Malonaldéhyde/métabolisme , Rats , Lésion d'ischémie-reperfusion/métabolisme , Superoxide dismutase/métabolisme
13.
Clin Anat ; 32(3): 439-445, 2019 Apr.
Article de Anglais | MEDLINE | ID: mdl-30664277

RÉSUMÉ

Urogenital complications due to pelvic autonomic nerve damage frequently occur following rectal surgery. We investigated whether total mesorectal excision (TME) with preservation of the Denonvilliers' fascia (DVF) can effectively prevent the removal of pelvic autonomic nerves through microscopy. Twenty consecutive male patients with mid-low rectal cancer who received TME with preservation or resection of the Denonvilliers' fascia (P and R groups, respectively) were included. Serial transverse sections from surgical specimens were studied histologically. Nerve fibers at the surfaces of the mesorectum were counted. Clinical correlation between the amount of nerve fibers removed and post-operative sexual function was analyzed. Nerve fibers closely localized to the DVF in the R group displaying rich erectile activity (positive anti-nNOS immunostaining). At the anterior surface of the mesorectum, the mean numbers of nNOS-positive nerve fibers per specimen in the P group were significantly lower than the R group (3.0 ± 1.8 vs. 5.0 ± 2.3, P < 0.05). Compared to the R group, patients in the P group had higher IIEF scores and better erectile function at 3 and 6 months post-operatively. The DVF is a key risk zone for pelvic denervation during laparoscopic TME. Preservation of the DVF can prevent the removal of autonomic nerves and protect post-operative erectile function. Clin. Anat. 32:439-445, 2019. © 2019 Wiley Periodicals, Inc.


Sujet(s)
Fascia/innervation , Tumeurs du rectum/chirurgie , Rectum/innervation , Adulte , Sujet âgé , Voies nerveuses autonomes/chirurgie , Dysfonctionnement érectile/étiologie , Humains , Laparoscopie , Mâle , Adulte d'âge moyen , Neurofibres/anatomopathologie , Traitements préservant les organes/méthodes , Pelvis/innervation , Périnée/innervation , Rectum/chirurgie
14.
Oxid Med Cell Longev ; 2018: 4780615, 2018.
Article de Anglais | MEDLINE | ID: mdl-30510620

RÉSUMÉ

BACKGROUND: Liver transplantation leads to liver ischemia/reperfusion (I/R) injury, resulting in early graft dysfunction and failure. Exacerbations of oxidative stress and inflammatory response are key processes in the development of liver I/R injury. Intravenous anesthetic propofol potent effects on free radical scavenging and protects livers against I/R injury. However, the role and mechanism of propofol-mediated hepatic protection in liver transplantation is poorly understood. The aim of this study was to evaluate the role of propofol postconditioning in the liver I/R injury after liver transplantation. METHODS: Forty-eight rats were randomly divided into six groups: rats receiving either sham operation or orthotopic autologous liver transplantation (OALT) in the absence or presence of propofol (high dose and low dose) postconditioning or intralipid control or VAS2870 (Nox2 special inhibitor). Eight hours after OALT or sham operation, parameters of organ injury, oxidative stress, inflammation, and NADPH-associated proteins were assessed. RESULTS: After OALT, severe liver pathological injury was observed that was associated with increases of serum AST and ALT, which were attenuated by propofol postconditioning. In addition, especially high dose of propofol postconditioning reduced TNF-α, IL-1ß, IL-6, TLR4, and NF-κB inflammatory pathway, accompanied with decrease of neutrophil elastase activity, MPO activity, 8-isoprotane, p47phox and gp91phox protein expressions, and increase of SOD activity. Inhibition of Nox2 by VAS2870 conferred similar protective effects in liver transplantation. CONCLUSION: Liver transplantation leads to severe inflammation and oxidative stress with NADPH oxidase activation. Propofol postconditioning reduces liver I/R injury after liver transplantation partly via inhibiting NADPH oxidase Nox2 and the subsequent inflammation and oxidative stress.


Sujet(s)
Apoptose , Hépatocytes/effets des médicaments et des substances chimiques , Transplantation hépatique/méthodes , Propofol/administration et posologie , Agents protecteurs/administration et posologie , Espèces réactives de l'oxygène/métabolisme , Lésion d'ischémie-reperfusion/prévention et contrôle , Anesthésiques intraveineux/administration et posologie , Animaux , Hépatocytes/métabolisme , Hépatocytes/anatomopathologie , Mâle , Stress oxydatif , Rats , Rat Sprague-Dawley , Lésion d'ischémie-reperfusion/métabolisme , Lésion d'ischémie-reperfusion/anatomopathologie
15.
BMC Gastroenterol ; 18(1): 152, 2018 Oct 19.
Article de Anglais | MEDLINE | ID: mdl-30340534

RÉSUMÉ

BACKGROUND: Perioperative serum potassium levels are closely associated with postoperative clinical outcomes after gastrointestinal surgery. The aim of our retrospective study was to identify the prevalence and risk factors for preoperative hypokalemia (before pneumoperitoneum) and to evaluate the influence of preoperative hypokalemia on the recovery of postoperative gastrointestinal function. METHODS: In this retrospective study, patients scheduled for laparoscopic colorectal resection from November 11 2014 to October 20 2016, were considered for inclusion. A blood potassium level between 3.5 and 5.5 mmol/L was defined as normal, with levels between 3.0 to 3.5 mmol/L, 2.5 to 3.0 mmol/L and < 2.5 mmol/L considered as slight, moderate, and severe level of hypokalemia. The factors including age, gender, ASA grade, BMI, hypertension, diabetes, anti-hypertension drugs, lactose oral soluble, oral cathartics, oral cathartics, cathartic enemas, and blood potassium level before gastrointestinal preparation which might be associated with blood potassium level before pneumoperitoneum were analysed. The time to postoperative first flatus (FFL) and first feces (FFE) was compared between patients with and without hypokalemia. RESULTS: The final analysis was based on the data of 108 patients. Hypokalemia was identified in 70.37% patients, with the following distribution of blood potassium levels before pneumoperitoneum: slight, 49 (45.37%) patients; moderate, 23 (21.30%); and severe, 4 (3.70%) patients. Hypokalemia was significantly associated with hypertension and the use of ≥2 types of oral cathartics for preoperative gastrointestinal preparation. With treatment, potassium levels recovered to normal levels in all patients within 48 h postoperatively. Hypokalemia was associated with a longer postoperative time to first feces, compared to patients with a normal potassium level before pneumoperitoneum. CONCLUSIONS: Our findings underlie the importance of early monitoring and management of serum potassium levels in these patients.


Sujet(s)
Côlon/chirurgie , Tube digestif/physiologie , Hypokaliémie/complications , Laparoscopie , Rectum/chirurgie , Sujet âgé , Sujet âgé de 80 ans ou plus , Cathartiques/administration et posologie , Côlon/physiologie , Défécation , Femelle , Météorisme , Humains , Hypertension artérielle/complications , Laparoscopie/méthodes , Mâle , Adulte d'âge moyen , Pneumopéritoine artificiel , Période postopératoire , Potassium/sang , Période préopératoire , Rectum/physiologie , Études rétrospectives , Facteurs de risque
16.
Cytometry A ; 93(10): 1004-1018, 2018 10.
Article de Anglais | MEDLINE | ID: mdl-30230197

RÉSUMÉ

Understanding the mechanisms and other variants of programmed cell death will help provide deeper insight into various disease processes. Although complex procedures are required to distinguish each type of cell death, the formation of vacuoles is one of the important features in some process of cell death under different conditions. Thus, monitoring and counting the number of vacuoles and the ratio of cells with vacuoles is a commonly used method to indicate and quantify the efficacy of the therapy. Several studies have shown that image processing can provide a quick, convenient and precise mean of performing cell detection. Hence, this study uses an image processing technique to detect and quantify vacuolated cells without the need for dyes. The system both counts the number of vacuolated cells and determines the ratio of cells with vacuoles. The performance of the proposed image processing system was evaluated using 38 images. It has been shown that a strong correlation exists between the automated counts and the manual counts. Furthermore, the absolute percentage errors between automated counts and manual counts for cell detection and vacuolated cell detection using data pooled from all images are 3.61 and 3.33%, respectively. A user-friendly graphical user interface (GUI) is also developed and freely available for download, providing researchers in biomedicine with a more convenient instrument for vacuolization analysis.


Sujet(s)
Automatisation/méthodes , Traitement d'image par ordinateur/méthodes , Vacuoles/anatomopathologie , Lignée cellulaire tumorale , Cellules HeLa , Humains
17.
Life Sci ; 204: 1-8, 2018 Jul 01.
Article de Anglais | MEDLINE | ID: mdl-29733849

RÉSUMÉ

BACKGROUND: Acute kidney injury occurred after sepsis, resulting in high mortality. This research aims to elucidate the mechanistic effect of DEX on the renal inflammation resolution during sepsis in rats. METHODS: The rats were randomly divided into a sham group and the other three cecal ligation and puncture (CLP) model groups, based on different treatments: placebo, DEX and 2-adrenergic receptor (AR) inhibitor atipamezole (AT) treatment (DEX + AT) groups. The survival of septic rats within 24 h was recorded. Tissue pathology, plasma IL-1ß, IL-6, TNF-α, lipoxygenase-5 and lipoxin A4 were evaluated. Western blotting and immunostaining was used to determine expression of TLR4, IκB, IKK, NF-κB p65 and pp65 in kidney tissue. Then qPCR was used to analyze the mRNA expression of renal α2A-AR, α2B-AR and α2C-AR. RESULTS: Rat mortality and kidney inflammation were significantly increased in septic rats. Specifically, IL-1ß, IL-6 and TNF-α plasma levels, NF-κB activity, and TLR4 expression in rat kidney tissues were increased after CLP. In the DEX treatment group, mortality was reduced, histology changes were minor, and lipoxygenase-5, and lipoxin A4 expression were increased. The expression of IL-1ß, IL-6 and TNF-α, NF-κB activity and TLR4 expression in rat kidney tissues were also decreased. These results indicated that DEX treatment alleviates acute kidney injury induced by CLP. However, the effects of DEX were apparently suppressed by atipamezole in the DEX + AT group. CONCLUSION: The current study demonstrated the protective effect of DEX on CLP-induced kidney injury, which may be effective by attenuating NF-κB pathway activation with lipoxin A4.


Sujet(s)
Atteinte rénale aigüe/traitement médicamenteux , Agonistes alpha-adrénergiques/usage thérapeutique , Dexmédétomidine/usage thérapeutique , Inflammation/traitement médicamenteux , Sepsie/traitement médicamenteux , Atteinte rénale aigüe/mortalité , Atteinte rénale aigüe/physiopathologie , Antagonistes des récepteurs alpha-2 adrénergiques/usage thérapeutique , Animaux , Maladies du caecum/physiopathologie , Caecum/traumatismes , Cytokines/métabolisme , Imidazoles/usage thérapeutique , Inflammation/physiopathologie , Rein/métabolisme , Mâle , Facteur de transcription NF-kappa B/effets des médicaments et des substances chimiques , Facteur de transcription NF-kappa B/métabolisme , Rats , Rat Sprague-Dawley , Récepteurs alpha-adrénergiques/effets des médicaments et des substances chimiques , Récepteurs alpha-adrénergiques/métabolisme , Sepsie/mortalité , Sepsie/physiopathologie , Récepteur de type Toll-4/effets des médicaments et des substances chimiques , Récepteur de type Toll-4/métabolisme
18.
J Mol Med (Berl) ; 96(5): 391-402, 2018 05.
Article de Anglais | MEDLINE | ID: mdl-29502203

RÉSUMÉ

Amantadine has been shown to reduce anesthesia and surgery-induced neuroinflammation and cognitive dysfunction. It is known that sepsis can impair brain function. We determined whether amantadine-attenuated sepsis-induced neuroinflammation and dysfunction of learning and memory and whether toll-like receptors (TLRs) play a role in the effects. Six- to eight-week-old mice were subjected to cecal ligation and puncture (CLP). Amantadine at 30 mg/kg/day was injected intraperitoneally for 3 days. CU-CPT22, a TLR1/TLR2 inhibitor, at 3 mg/kg/day was injected intraperitoneally for 2 days. Mice were subjected to Barnes maze and fear conditioning tests from 1 week after CLP. CLP induced neuroinflammation and cognitive dysfunction. CLP also increased the expression of toll-like receptor 2 (TLR2), TLR4, and TLR9, three major TLRs in the brain, in CD-1 male mice. Amantadine attenuated CLP-induced neuroinflammation and dysfunction of learning and memory but did not have significant effects on the expression of TLRs. CU-CPT22 also attenuated sepsis-induced neuroinflammation and cognitive dysfunction. Similarly, sepsis induced neuroinflammation and cognitive dysfunction in the C57BL/6J mice. Interestingly, sepsis also induced neuroinflammation and cognitive dysfunction in the TLR2 knockout mice. The effects of amantadine on the neuroinflammation and cognitive dysfunction were still apparent in these knockout mice. TLR2 contributes to sepsis-induced neuroinflammation and cognitive dysfunction. However, inhibiting TLR2 may not be a major mechanism for amantadine to inhibit sepsis-induced neuroinflammation and cognitive dysfunction. KEY MESSAGES: Sepsis induces neuroinflammation and cognitive impairment, which were attenuated by amantadine. Toll-like receptors 2 mediates these sepsis effects but may not be the major target for amantadine to reduce these effects.


Sujet(s)
Amantadine/usage thérapeutique , Dysfonctionnement cognitif/traitement médicamenteux , Neuroprotecteurs/usage thérapeutique , Sepsie/traitement médicamenteux , Récepteurs de type Toll/métabolisme , Amantadine/pharmacologie , Animaux , Comportement animal/effets des médicaments et des substances chimiques , Dysfonctionnement cognitif/étiologie , Dysfonctionnement cognitif/métabolisme , Hippocampe/effets des médicaments et des substances chimiques , Hippocampe/métabolisme , Mâle , Apprentissage du labyrinthe/effets des médicaments et des substances chimiques , Souris de lignée C57BL , Souris knockout , Neuroprotecteurs/pharmacologie , Sepsie/complications , Sepsie/métabolisme , Récepteurs de type Toll/génétique
19.
Mediators Inflamm ; 2018: 6158671, 2018.
Article de Anglais | MEDLINE | ID: mdl-30670927

RÉSUMÉ

BACKGROUND: Inflammatory responses induced by intestinal ischemia-reperfusion (IIR) lead to serious systemic organ dysfunction and pose a challenge for current treatment. This study aimed at investigating the effects of resveratrol on IIR-induced intestinal injury and its influence on mast cells (MCs) in rats. METHODS: Rats subjected to intestinal ischemia for 60 min and 4 h of IIR were investigated. Animals were randomly divided into five groups (n = 8 per group): sham, IIR, resveratrol (RESV, 15 mg/kg/day for 5 days before operation) + IIR, cromolyn sodium (CS, MC membrane stabilizer) + IIR, and RESV + compound 48/80 (CP, MC agonist) + IIR. RESULTS: Intestinal injury and increased proinflammatory cytokines including tumor necrosis factor-α, interleukin-1ß, and interleukin-18 were observed in the IIR group. Intestinal MC-related tryptase and ß-hexosaminidase levels were also increased after rats were subjected to IIR accompanied by activation of NLRP3 inflammasomes. Interestingly, pretreatment with resveratrol significantly suppressed the activities of proinflammatory cytokines and attenuated intestinal injury. Resveratrol also reduced MC and NLRP3 inflammasome activation, which was consistent with the effects of cromolyn sodium. However, the protective effects of resveratrol were reversed by the MC agonist compound 48/80. CONCLUSIONS: In summary, these findings reveal that resveratrol suppressed IIR injury by stabilizing MCs, preventing them from degranulation, accompanied with intestinal mucosa NLRP3 inflammasome inhibition and intestinal epithelial cell apoptosis reduction.


Sujet(s)
Inflammasomes/métabolisme , Mastocytes/effets des médicaments et des substances chimiques , Mastocytes/métabolisme , Protéine-3 de la famille des NLR contenant un domaine pyrine/métabolisme , Resvératrol/usage thérapeutique , Animaux , Apoptose/effets des médicaments et des substances chimiques , Technique de Western , Technique d'immunofluorescence , Hexosaminidases/métabolisme , Méthode TUNEL , Inflammasomes/effets des médicaments et des substances chimiques , Interleukine-18/métabolisme , Interleukine-1 bêta/métabolisme , Mâle , Rats , Rat Sprague-Dawley , Lésion d'ischémie-reperfusion/traitement médicamenteux , Lésion d'ischémie-reperfusion/métabolisme , Facteur de nécrose tumorale alpha/métabolisme
20.
ANZ J Surg ; 87(4): 247-251, 2017 Apr.
Article de Anglais | MEDLINE | ID: mdl-25331064

RÉSUMÉ

BACKGROUND: The presence of nodal metastases in rectal cancer plays an important role in accurate staging and prognosis, which depends on adequate lymph node harvest. The aim of this prospective study is to investigate the feasibility and survival benefit of improving lymph node harvest by a modified method with methylene blue injection in rectal cancer specimens. METHODS: One hundred and thirty-one patients with rectal cancer were randomly assigned to the control group in which lymph nodes were harvested by palpation and sight, or to the methylene blue group using a modified method of injection into the superior rectal artery with methylene blue. Analysis of clinicopathologic records, including a long-term follow-up, was performed. RESULTS: In the methylene blue group, 678 lymph nodes were harvested by simple palpation and sight. Methylene blue injection added 853 lymph nodes to the total harvest as well as 32 additional metastatic lymph nodes, causing a shift to node-positive stage in four patients. The average number of lymph nodes harvested was 11.7 ± 3.4 in the control group and 23.2 ± 4.7 in the methylene blue group, respectively. The harvest of small lymph nodes (<5 mm) and the average number of metastatic nodes were both significantly higher in the methylene blue group. The modified method of injection with methylene blue had no impact on overall survival. DISCUSSION: The modified method with methylene blue injection improved lymph node harvest in rectal cancer, especially small node and metastatic node retrieval, which provided more accurate staging. However, it was not associated with overall survival.


Sujet(s)
Lymphadénectomie/méthodes , Noeuds lymphatiques/anatomopathologie , Noeuds lymphatiques/chirurgie , Bleu de méthylène/administration et posologie , Tumeurs du rectum/chirurgie , Femelle , Humains , Injections artérielles , Métastase lymphatique , Mâle , Adulte d'âge moyen , Stadification tumorale , Pronostic , Études prospectives , Tumeurs du rectum/mortalité , Tumeurs du rectum/anatomopathologie , Coloration et marquage/méthodes , Analyse de survie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...